#United States #Phoenix #Trinity Capital #Cala Health #Tremor Therapy

Trinity Capital Inc. Invests in the Future of Tremor Therapy

Trinity Capital Inc., a prominent alternative asset manager, recently announced a dedicated investment of $50 million aimed at supporting the growth of Cala Health, a pioneering company specializing in bioelectronic medicine. This partnership is particularly significant as it focuses on advancing a wearable device designed to treat tremors caused by Parkinson's disease and essential tremor, thus enhancing the quality of life for patients afflicted with these conditions.

An Innovative Approach to Tremor Management

Cala Health has developed the Cala kIQ® System, an FDA-cleared wearable device that provides patients with a method to manage their symptoms effectively. Worn on the wrist, this device captures a patient’s unique tremor patterns and delivers tailored electrical stimulation to mitigate tremors noninvasively. The technology allows individuals to receive therapy in the comfort of their homes, empowering them to regain control over daily activities such as writing, reading, and even eating.

The integration of Trinity Capital's growth capital is expected to accelerate this innovative therapy's commercial expansion. According to Rob Lake, Senior Managing Director of Life Sciences at Trinity Capital, the partnership represents a shared commitment to enhancing patient outcomes through effective and personalized treatment options.

The Implications of This Investment

Cala Health's CEO, Deanna Harshbarger, expressed optimism about the collaboration, emphasizing that this financial support will fortify Cala's capital structure. With the new investment, Cala Health can expedite its goals of commercial expansion and further product innovation. The commitment from Trinity Capital also highlights the growing recognition of bioelectronic medicine as a viable solution for chronic conditions that affect millions worldwide.

As Cala continues to refine its therapeutic offerings, it aims to broaden the reach of its Cala TAPS® therapy. This initiative seeks to make a significant impact on the lives of those affected by essential tremor and Parkinson’s disease, thus transforming how these chronic conditions are managed.

The Vision Behind Trinity Capital

Trinity Capital Inc. operates as a long-term partner for innovative companies. By focusing on delivering tailored debt solutions, Trinity has successfully deployed over $5.5 billion through various investments since its inception in 2008. This notable track record underscores the company’s dedication to fostering growth in sectors such as life sciences, where cutting-edge advancements can provide significant benefits.

Headquartered in Phoenix, Arizona, Trinity has positioned itself as a critical player in the realm of alternative asset management, ensuring that companies like Cala Health have the necessary resources to flourish. This partnership serves as a hallmark of Trinity's strategy to support forward-thinking companies that are reshaping their industries.

Conclusion: A Future of Hope for Patients

As the healthcare landscape evolves, initiatives like the collaboration between Trinity Capital and Cala Health pave the way for innovative solutions to emerge. The commitment of $50 million demonstrates a robust belief in the potential of wearable technology to enhance patient care and management of chronic diseases. As Cala Health prepares for the next stages of its growth, both companies stand at the forefront of a movement aimed at improving the lives of countless individuals facing the challenges of tremors caused by chronic conditions. This partnership not only signifies a financial commitment but also a shared vision of a future where patients can live life more freely, unhindered by the limitations of their conditions.

For more information about Trinity Capital and Cala Health, please visit their respective websites.